Bioelectronics Corp (BIEL)

[DewmBoom]

Biel is the only company in the world that has a PEMF wearable device clearance to sell in the United States of America Over the Counter without a prescription.

The Actipatch is a Class II device that cleared to sell OTC for the adjunctive treatment of knee and foot pain. The FDA created a special category to clear the Actipatch OTC because of its significance!!!!

The Actipatch will soon get the back pain clearance and the general use clearance. This will happen as soon as Oxford University completes the Backpain Clinical Trial:

What is Unique About the Actipatch

Zero Competition. Literally, there is no other OTC PEMF wearable devices available for adjunctive treatment

Zero Side Effects
Full Patent Protection
Clinical Trials with Real World Data that shows significant PAIN REDUCTION

The Actipatch provides a huge market barrier to any potential competition with their trial device of one week at $9.95. This must be frustrating to the potential competitors because Biel destroyed them. Biel also spent a minimal amount of money to reach this milestone.

That is why the success of Biel is irreversible. That is why Dewboom is treating Biel as an early retirement stock by the end of 2018!!!!!

THINK ABOUT AND DIVE IN. For long term investors, there isn't much difference between 6, 7, 8, 10, 20, etc....